Why AI technology could mean a breakthrough year for rare disease diagnosis
Dr Peter Fish, CEO of Mendelian, explores the benefits of Artificial Intelligence in the diagnosis processes of rare diseases. His discussion focuses on the UK healthcare environment and how it could be a catalyst for globa...